Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of CTS-1027 in Hepatitis C Patients

ClinicalTrials.gov ID: NCT00570336

Public ClinicalTrials.gov record NCT00570336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose Response Study of CTS-1027 in Hepatitis C Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if CTS-1027 can lower elevated liver enzymes in patients with chronic HCV infection.

Study identification

NCT ID
NCT00570336
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2007 (Type not available)
Primary completion
Jul 2009 (Actual)
Completion
Jul 2009 (Actual)
Last update posted
Sep 16, 2010

2007 – 2009

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Scripps Clinic La Jolla California 92037 —
Kaiser Permanente San Diego California 92154 —
California Pacific Medical Center San Francisco California 94115 —
University of Colorado Denver Aurora Colorado 80045 —
University of Miami Miami Florida 33136 —
Digestive Healthcare of Georgia Atlanta Georgia 30309 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Health System West Bloomfield Michigan 48322 —
Mayo Clinic Rochester Minnesota 55905 —
Mt. Sinai School of Medicine New York New York 10019 —
Bronx VA Medical Center The Bronx New York 10468 —
Duke University Medical Center Durham North Carolina 27710 —
Consultants of Clinical Research Cincinnati Ohio 45219 —
Cleveland Clinic Cleveland Ohio 44195 —
Advanced Liver Therapies - Baylor College of Medicine Houston Texas 77030 —
VAMC - Baylor College of Medicine Houston Texas 77030 —
McGuire Hospital DVAMC Richmond Virginia 23249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00570336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2010 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00570336 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →